期刊文献+

2175例宫颈癌患者住院病历资料分析 被引量:7

Analysis on the medical records of 2 175 hospitalized patients with cervical cancer
原文传递
导出
摘要 目的:探讨宫颈癌患者的发病年龄、组织学病理类型、临床分期及接受治疗情况,对宫颈癌的流行病学研究及宫颈癌的早期预防宣传教育提供临床依据。方法:顺序选取2002年1月~2008年12月江西省妇幼保健院肿瘤科收治的宫颈癌患者2 175例作为研究对象,对其进行回顾性研究,就宫颈癌患者就诊时的年龄构成分布、组织病理类型、临床分期及治疗手段等进行分析,临床分期采用国际妇产科联盟(FIGO)(1994年)。结果:2 175例宫颈癌患者中接受宫颈癌手术治疗992例,接受根治性放疗或放化疗患者1 183例。研究对象中,按照1994年FIGO临床分期,其中ⅠA1期17例,ⅠA2期28例,ⅠB1期491例,ⅠB2期361例,ⅡA期151例,ⅡB期606例,ⅢA期28例,ⅢB期487例,Ⅳ期6例。按照宫颈组织病理类型划分,其中宫颈鳞癌1 887例(86.76%),宫颈腺癌216例(9.93%),腺鳞癌30例(1.38%),鳞腺癌22例(1.01%),其他类型共计20例(0.92%)。患者年龄按照≤25岁、26岁~、31岁~、36岁~、41岁~、46岁~、51岁~、56岁~、>60岁共分为9个年龄组,各年龄组宫颈癌患者例数分别为19例(0.87%),78例(3.59%),195例(8.96%),389例(17.88%),464例(21.33%),385例(17.70%),293例(13.47%),150例(6.90%),202例(9.29%)。其中35岁及以下年轻宫颈癌患者共计292例,占全部患者的13.42%。中晚期宫颈癌(ⅡB期以上)患者多于早期宫颈癌患者。结论:宫颈癌发病呈年轻化趋势,发病高峰年龄为36~50岁,提高妇女对宫颈癌早期筛查的宣传教育工作可降低中晚期宫颈癌的发病率。 Objective: To explore the onset age, histopathological types, clinical stages, and treatment of the patients with cervical cancer, provide a clinical basis for epidemiological research, publicity and education of early prevention of cervical cancer. Methods : A total of 2 175 patients with cervical caner who were treated in tumor department of the hospital from January 2002 to December 2008 were selected in sequence as study objects, then a retrospective study was conducted, the constitution and distribution of age, histopathological types, clinical stages, and treatment of the patients were analyzed; FIGO (1994) was adopted for clinical staging. Results: Among 2 175 patients with cervical cancer, 992 patients received surgery, and 1 183 patients received radical radiotherapy or radiotherapy combined with chemotherapy. According to FIGO clinical staging in 1994, 17 cases with stage Ⅰ A1, 28 cases with stage Ⅰ A2, 491 cases with stage Ⅰ B1, 361 cases with stage Ⅰ B2, 151 cases with stage ⅡA, 606 cases with stage ⅡB, 28 cases with stage ⅢA, 487 cases with stage ⅢB, and 6 cases with stage Ⅳ were included into the study objects. According to histopathological types of cervical cancer, 1 887 cases (86. 76% ) with cervical sqnamous cell carcinoma, 216 cases (9. 93% ) with cervical adenocarcinoma, 30 cases ( 1.38% ) with cervical adenosquamous carcinoma, 22 cases (1.01%) with cervical squamous adenocarcinoma, and 20 cases (0. 92% ) with other types were included into the study objects. The patients were divided into nine groups according to age: ≤25 - year - old group ( 19 cases, 0. 87% ) , 26- 30- yearold group (78 cases, 3.59% ), 31 -35 -yearold group (195 cases, 8.96% ), 36 -40 -year- old group (389 cases, 17.88% ) , 41 -45 - year - old group (464 cases, 21.33% ) , 46 - 50 - year - old group (385 cases, 17.70% ) , 51 - 55 - year - old group (293 cases, 13.47% ) , 56 - 60 - year - old group ( 150 cases, 6. 90% ) , and 〉 60 - year - old group (202 cases, 9.29% ) . Two hundred and ninety - two patients were 35 years old or less than 35 years, accounting for 13.42%. The number of patients with cervical cancer in intermediate and advanced stages (above stage ⅡB ) was more than that of patients with cervical cancer in early stage. Conclusion: The onset of cervical cancer shows a tendency toward young, the peak age is 36 - 50 - year, improving publicity and education of early screening of cervical cancer among women can reduce the prevalence of cervical cancer in intermediate and advanced stages.
出处 《中国妇幼保健》 CAS 北大核心 2012年第17期2592-2594,共3页 Maternal and Child Health Care of China
关键词 宫颈癌 年龄 病理类型 临床分期 Cervical cancer Age Pathological type Clinical staging
  • 相关文献

参考文献6

  • 1Bray F, Carstensen B, Moller Het al. Incidence trends of ade- nocarcinoma of the cervix in 13 European countries [J]. Cancer Epidcmiol Biomark Prey, 2005, 14:2191 -9.
  • 2Castellsague X, Diaz M, De Sanjose S et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its co- factors: implications for screening and prevention [ J ] . J Natl Cancer Inst, 2006, 98: 303- 15.
  • 3Lea JS, Coleman RL, Garner EO et al. Adenosquamous histol- ogy predicts poor outcome in low - risk stage IB1 cervical ade- nocarcinoma [J]. Gynecol Oncol, 2003, 91:558-62.
  • 4Schlaerth JB, Spirtos NM, Schlaerth AC. Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer [J]. Am J Obstet Gynecol, 2003, 188:29-34.
  • 5Rob L, Charvat M, Robova Het al. Less radical fertility - sparing surgery than radical trachelectomy in early cervical cancer [J]. Int J Gynecol Cancer, 2007, 17:304 - 10.
  • 6章文华,白萍,吴令英,马绍康.35岁以下妇女宫颈癌[J].中国肿瘤临床与康复,1999,6(6):39-41. 被引量:127

二级参考文献4

共引文献126

同被引文献63

  • 1黄秀凤,林凤若,白满.社会支持对宫颈癌术后患者生活质量的影响[J].国际护理学杂志,2007,26(9):976-977. 被引量:7
  • 2Smith JH. Bethesda 2001[J]. Cytopathology, 2002, 13(1):4-101.
  • 3Manrit K Leinonen, pekka Nieminen, Stefan Lormberg, et al. detection rates of precancerous and cancerous cervical lesions witlhin one screening round of primary liuman papillomavirus DNA testing: prospec-five randomised trial in Finland[J].BMJ,2012,345:e7789.
  • 4Herfs hi, Yammnoto Y,Laury A, et 81. A discrete population of squamo- columnar junction cells implicated in the pathogenesis of cervical cancer [J].Proe Natl Aead Sei USA,2012,26,109 (26):10516-10521.
  • 5Frega A,StenteUa P,De Ioris A,et al. Young women,cervical intraepithe- lial neoplasia and human papillomavirus: risk factors for persistence an d recurrence [J].Cancer Lett,2003,196(2):127-134.
  • 6Cuzick d,Bergeron C,'von Knebel Doeberitz M, et al New tecbnolo- gies and procedures for cervical CanCer screening[J].Vaccine,2012,20 (30 SupplS):F107-F11 6.
  • 7Castle PE,Gravitt PE, Wentzensen N,et al. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 follow- ing minor cytologic abnormalities [J].Am J Clin Pathol,2012,138(2): 241-246.
  • 8徐洁.2002—2006年681例妇科恶性肿瘤病例统计分析[J].中国医院统计,2007,14(4):359-360. 被引量:3
  • 9Wallach JB, Rosenstein MM, Kalnicki S. Localized synchronous squamous cell carcinomas of the esophagus and hypopharynx treated with definitive concurrent chemomdiotherapy with a unified radiother- apy plan. Curr Oncol, 2014,21 (2) :354 -557.
  • 10Ahn D, Kim JH, Sohn JH, et al. Laryngeal preservation in stage Ill/ IV resectable laryngo - hypopharyngeal squamous cell carcinoma fol- lowing concurrent chemoradiotherapy with capecitabine/cisplatin. Mol Clin 0ncol,2013,1 (4) :685 -691.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部